THE PROSPECTIVE CARDIOVASCULAR MUNSTER (PROCAM) STUDY - PREVALENCE OF HYPERLIPIDEMIA IN PERSONS WITH HYPERTENSION AND OR DIABETES-MELLITUS AND THE RELATIONSHIP TO CORONARY HEART-DISEASE

被引：352

作者：

ASSMANN, G ^{[1
]}

SCHULTE, H ^{[1
]}

机构：

[1] UNIV MUNSTER, INST ARTERIOSCLEROSIS, D-4400 MUNSTER, GERMANY

来源：

关键词：

D O I：

10.1016/0002-8703(88)90220-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1713 / 1724

页数：12

共 25 条

[1] [Anonymous], 1978, J Chronic Dis, V31, P201
[2] ASSMANN G, 1980, INTERNIST, V21, P446
[3] THE PROSPECTIVE CARDIOVASCULAR MUNSTER STUDY - PREVALENCE AND PROGNOSTIC-SIGNIFICANCE OF HYPERLIPIDEMIA IN MEN WITH SYSTEMIC HYPERTENSION
ASSMANN, G
SCHULTE, H
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (14) : G9 - G17
[4] ASSMANN G, 1986, PROCAM STUDIE
[5] ASSMANN G, 1986, ATHEROSCLEROSIS, V7, P19
[6] BERNSTEIN MJ, 1985, JAMA-J AM MED ASSOC, V253, P2080
[7] BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS
BLANKENHORN, DH
NESSIM, SA
JOHNSON, RL
SANMARCO, ME
AZEN, SP
CASHINHEMPHILL, L
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23): : 3233 - 3240
[8] CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36
[9] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE
FRICK, MH
ELO, O
HAAPA, K
HEINONEN, OP
HEINSALMI, P
HELO, P
HUTTUNEN, JK
KAITANIEMI, P
KOSKINEN, P
MANNINEN, V
MAENPAA, H
MALKONEN, M
MANTTARI, M
NOROLA, S
PASTERNACK, A
PIKKARAINEN, J
ROMO, M
SJOBLOM, T
NIKKILA, EA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) : 1237 - 1245
[10] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499